Schedule 13G ownership disclosure
LA JOLLA PHARMACEUTICAL CO
Security class unavailable · CUSIP: 503459604
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 356,199
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-19-000051
- Form type
- SC 13G
- Filer
- LA JOLLA PHARMACEUTICAL CO
- CIK
- CIK 920465
- Filed
- Feb 08, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership